Achieve Life Sciences Financial Statements
NASDAQ: QUITHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
5.56-0.31 (-5.28%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Achieve Life Sciences revenue and earnings
Achieve Life Sciences reported a net loss of $54.6 million, compared with a loss of $39.8 million a year earlier. Diluted earnings per share came in at -$1.25.
Summary generated from market data by MetaCap's automated system. Methodology
Achieve Life Sciences income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | 0 | 0 | — | — |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| Research & Development | — | 22.82M | 15.81M | 30.08M | 23.97M | 6.88M | 9.67M | 5.87M | 3.10M | 286.00K |
| Interest Expense | 819.00K | 2.18M | 2.85M | 1.79M | — | — | — | — | — | — |
| Other Income (Expense) | 232.00K | -758.00K | -2.56M | -1.55M | -58.00K | 20.00K | 133.00K | 126.00K | -7.00M | -24.00K |
| Pretax Income | -54.65M | -39.83M | -29.82M | -42.35M | -33.15M | -14.73M | -16.39M | -12.69M | -13.63M | -1.74M |
| Income Tax | — | — | — | — | — | — | — | — | — | 0 |
| Net Income | -54.65M | -39.83M | -29.82M | -42.35M | -33.15M | -14.73M | -16.39M | -12.69M | -10.58M | -1.23M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -1.25 | -1.24 | -1.50 | -4.00 | -4.08 | -5.42 | -39.76 | -72.29 | -22.07 | -581.25 |
| EPS (Diluted) | -1.25 | -1.24 | -1.50 | -4.00 | -4.08 | -5.42 | -39.76 | -72.29 | -22.07 | -581.25 |
| Shares Outstanding (Basic) | 43.59M | 32.07M | 19.83M | 10.59M | 8.12M | 2.72M | 412.32K | 175.51K | 479.44K | 2.12K |
| Shares Outstanding (Diluted) | 43.59M | 32.07M | 19.83M | 10.59M | 8.12M | 2.72M | 412.32K | 175.51K | 479.44K | 2.12K |
This table shows 10 annual periods of Achieve Life Sciences's income statement, from FY 2025 back to FY 2016, across 12 line items including revenue, operating expenses, research & development. Values in USD; B = billions, M = millions. Fiscal periods follow QUIT's reporting calendar. What is a income statement?